The Psychedelic CDMOTM
CMC Services
Our Mission
To reconnect humanity, Psygen will improve access to psychedelics.
We exist to support the development of psychedelic and neuroplastogen Active Pharmaceutical Ingredients (“APIs”).
Our Facility /
Psygen’s State- of-the-Art Facility
Expanding Access
As a part of Psygen’s mission to improve access to psychedelics, we have donated psychedelic drug substances to physicians through Canada’s Special Access Program, including for the first use of psilocybin through the SAP in 2022. Psygen has also donated psychedelic APIs for humanitarian projects around the world.
If you are operating a research or humanitarian project that requires access to LSD, MDMA, psilocybin or other psychedelics, please reach out to discuss how Psygen can support your project.
Our Impact /
Psygen Worldwide
Since 2019, Psygen has been dedicated to the production of psychedelic medicines – quietly planting seeds of change around the world. We believe actions speak louder than words, and have developed this live interactive map to show the impact of our work.